NCT03372473View on ClinicalTrials.gov

Montelukast and Loratadine in Children With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 10, 2016

Primary Completion Date

February 1, 2016

Study Completion Date

June 30, 2017

Conditions
Asthma in Children
Interventions
DRUG

Montelukast mixed with Loratadine

Montelukast 5mg mixed with Loratadine 5mg, one dose per day

DRUG

Montelukast

Montelukast 5mg

All Listed Sponsors
collaborator

National Institute of Pediatrics, Mexico

OTHER_GOV

collaborator

Laboratorios Senosiain, S.A. de C.V.

INDUSTRY

lead

Innovacion y Desarrollo de Estrategias en Salud

OTHER

NCT03372473 - Montelukast and Loratadine in Children With Asthma | Biotech Hunter | Biotech Hunter